We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

113 hedge funds and large institutions have $323M invested in Emergent Biosolutions in 2013 Q2 according to their latest regulatory filings, with 113 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64.42% more ownership

Funds ownership: 0% → 64.42% (+64%)

Holders
113
Holders Change
+113
Holders Change %
–
% of All Funds
3.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
113
Increased
–
Reduced
–
Closed
–
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
1
Bank of New York Mellon
New York
$49.3M +$49.5M +3,420,502 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$24.5M +$24.6M +1,697,223 New
BFA
3
BlackRock Fund Advisors
California
$18.7M +$18.8M +1,298,360 New
BC
4
Broadfin Capital
New York
$15.5M +$15.6M +1,074,248 New
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$15.2M +$15.2M +1,051,056 New
CCM
6
Consonance Capital Management
New York
$14.2M +$14.2M +983,669 New
State Street
7
State Street
Massachusetts
$14M +$14.1M +970,402 New
BIT
8
BlackRock Institutional Trust
California
$13.3M +$13.4M +925,690 New
KCM
9
Kingdon Capital Management
New York
$10.8M +$10.8M +749,104 New
Renaissance Technologies
10
Renaissance Technologies
New York
$10.4M +$10.5M +723,811 New
UBS AM
11
UBS AM
Illinois
$8.1M +$8.13M +561,583 New
SCA
12
SAC Capital Advisors
Connecticut
$7.65M +$7.68M +530,665 New
AQR Capital Management
13
AQR Capital Management
Connecticut
$7.53M +$7.56M +522,001 New
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$7.22M +$7.25M +500,826 New
Northern Trust
15
Northern Trust
Illinois
$6.08M +$6.11M +421,776 New
Invesco
16
Invesco
Georgia
$5.72M +$5.74M +396,460 New
Fisher Asset Management
17
Fisher Asset Management
Washington
$5.68M +$5.7M +393,595 New
Fidelity Investments
18
Fidelity Investments
Massachusetts
$5.63M +$5.65M +390,208 New
Millennium Management
19
Millennium Management
New York
$5.32M +$5.35M +369,225 New
CCMH
20
Cornerstone Capital Management Holdings
New York
$3.66M +$3.68M +253,877 New
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$3.58M +$3.6M +248,303 New
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.9M +$2.91M +201,085 New
TCIM
23
TIAA CREF Investment Management
New York
$2.9M +$2.91M +201,001 New
RFC
24
Russell Frank Company
Washington
$2.75M +$2.77M +190,960 New
SBH
25
Segall Bryant & Hamill
Illinois
$2.64M +$2.65M +183,075 New
1
2 3 4 5

EBS Hedge Fund Activity: Q2 2013 in Review

113 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q2 2013, worth a combined $323M.

Buyers outnumbered sellers: 113 funds opened new EBS positions and 0 closed out — a net gain of 113 holders — while 0 added to existing stakes and 0 trimmed.

  • 113 institutional investors held Emergent Biosolutions (EBS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $323M of Emergent Biosolutions stock for Q2 2013.
  • 113 funds opened new Emergent Biosolutions positions in Q2 2013 and 0 closed out, a net change of +113 holders.

Based on aggregated 13F filings for Q2 2013.